Cardiovascular high-risk patients--treat to protect, but whom?

Faiez Zannad1, Anne Jakobsen, Jose Heroys

  • 1Hypertension and Heart Failure Unit, INSERM Clinical Investigation Centre, Nancy, France. f.zannad@chu-nancy.fr

Insights

Assessing global cardiovascular risk is crucial for preventing coronary heart disease. The Systematic COronary Risk Evaluation (SCORE) project offers risk charts for European populations, improving risk assessment beyond the Framingham algorithm.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Current coronary heart disease prevention guidelines stress global cardiovascular risk assessment.
  • The Framingham algorithm is a common tool but has limitations in European populations, especially low-risk ones.
  • Hypertension significantly increases coronary heart disease risk, often underestimated in clinical practice.

Purpose of the Study:

  • To evaluate cardiovascular risk stratification methods for coronary heart disease prevention.
  • To compare the applicability of the Framingham algorithm and the Systematic COronary Risk Evaluation (SCORE) project in European countries.
  • To highlight the importance of accurate risk assessment in hypertensive patients.

Main Methods:

  • Utilized the Framingham algorithm for cardiovascular risk stratification.
  • Employed the Systematic COronary Risk Evaluation (SCORE) risk charts for European populations.
  • Reviewed data on end-organ damage and additional biomarkers for prognostic information.
  • Analyzed results from major intervention trials on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Main Results:

  • The Framingham algorithm is not universally applicable, particularly in low-risk European countries.
  • The SCORE project provides risk charts tailored for both low-risk and high-risk European countries.
  • Cardiovascular risk is frequently underestimated in clinical practice, especially in high-risk hypertensive patients.
  • Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers demonstrate significant cardiovascular event risk reduction across all risk levels.

Conclusions:

  • Accurate cardiovascular risk stratification is essential for effective coronary heart disease prevention.
  • The SCORE project offers a more geographically relevant tool for European populations compared to the Framingham algorithm.
  • Intervention with specific medications provides substantial benefits, particularly for high-risk individuals.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.